AxoGen (AXGN) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 10/21/26
Axogen, Inc. to Report Third Quarter 2026 Financial Results on October 28, 2026GlobeNewsWire • 10/14/26
Down 22.6% in 4 Weeks, Here's Why You Should You Buy the Dip in AxoGen (AXGN)Zacks Investment Research • 10/05/26
Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve RepairGlobeNewsWire • 10/01/26
Axogen Raises $200 Million to Fund BioCircuit Buyout Focused on Sutureless Nerve RepairBenzinga • 09/10/26
Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare ConferenceGlobeNewsWire • 09/01/26
Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026GlobeNewsWire • 07/15/26